ViiV in late-stage HIV trial success
September 23, 2015Research and Development HIV, Triumeq, ViiV, virology
Switching patients to Triumeq, a once-daily combination treatment for HIV, is as effective as remaining on antiretroviral therapy in certain …
Pharma ‘is getting better at drug R&D’
September 23, 2015Research and Development R&D, drug development, market access, productivity
An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …
Novo Nordisk to build manufacturing plant for FlexPen in Iran
September 22, 2015Manufacturing and Production Iran, Novo Nordisk, diabetes
Novo Nordisk has announced that Novo Nordisk Iran and the Food and Drug Administration of the Islamic Republic of Iran …
Anger as drug price rises from $13.50 to $750 overnight
September 22, 2015Manufacturing and Production, Sales and Marketing pyrimethamine, turing
Turing founder Martin Shkreli has been forced to defend the company’s decision to raise the price of the drug Daraprim …
Vision for hi-tech manufacturing in the Scottish highlands
September 22, 2015Manufacturing and Production, Research and Development GSK, Scotland, manufacturing
Scottish life and chemical science firms claim Scotland is an ideal European base for UK and global manufacturers. A new …
Pfizer and GSK in antidepressant safety probes
September 22, 2015Manufacturing and Production GSK, Paxil, Pfizer, Zoloft, antidepressants, drug safety, paroxetine, sertraline
Two top-selling antidepressants have had their safety records challenges, after the FDA asked Pfizer to change the labelling of its …
Featured market report: Cancer diagnostics market – Forecast to 2020
September 22, 2015Manufacturing and Production, Sales and Marketing cancer diagnostics, market report, marketsandmarkets
The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms.Moreover, the market …
Shire ADHD treatment Intuniv gets EU approval
September 21, 2015Sales and Marketing ADHD, Shire, attention deficit hyperactivity disorder, intuniv
The European Commission has granted marketing authorisation for Shire’s Intuniv for the treatment of ADHD in children. Intuniv (guanfacine hydrochloride prolonged …
Working Life: Novo Nordisk’s Klaus Henning-Jensen
September 21, 2015Sales and Marketing Novo Nordisk, Working Life
How did you find your way into your current role?I started out in medicine at Bispebjerg, which is a large …
Amgen’s Kyprolis gets accelerated FDA review for expanded labelling
September 21, 2015Sales and Marketing Amgen, FDA, Kyprolis, carfilzomib, multiple myeloma
The FDA has accepted for priority review Amgen’s supplemental new drug application for Kyprolis (carfilzomib) for patients with relapsed multiple …
Roche to present new Esbriet data at ERS Congress 2015
September 21, 2015Research and Development, Sales and Marketing Esbriet, European Respiratory Congress, Roche, idiopathic pulmonary fibrosis, pirfenidone
Roche has announced it will present new data analyses of Esbriet in idiopathic pulmonary fibrosis (IPF) at the European Respiratory …
More positive CV data for Boehringer and Lilly’s Jardiance
September 21, 2015Research and Development, Sales and Marketing Boehringer Ingelheim, EASD, Eli Lilly, cardiovascular risk, empagliflozin, jardiance, mortality risk, type 2 diabetes
Jardiance, an anti-diabetes drug produced by Boehringer Ingelheim and Eli Lilly, reduces the risk of death in people with type …
Biocair opens new site in Belgium
September 21, 2015Research and Development, Sales and Marketing Biocair
Biocair is pleased to announce the opening of its new premises in Belgium. The new state of the art facility …
FDA grants Opdivo breakthrough status for kidney cancer
September 18, 2015Research and Development, Sales and Marketing BMS, Breakthrough Therapy Designation, Bristol-Myers Squibb, FDA, Kidney cancer, immuno-oncology, immunotherapy, nivolumab, opdivo, renal cell carcinoma
The FDA has given Bristol-Myers Squibb’s immuno-oncology drug Opdivo Breakthrough Therapy Designation as a kidney cancer treatment. The FDA’s decision …
Bedrock Healthcare communications appoints new head of med comms
September 18, 2015Medical Communications Andy Grigg, Bedrock
Andy Grigg has joined Bedrock Healthcare Communications as head of medical communications. Grigg joins from Inspired Science where he was practice …
Report identifies digital trends in life sciences industry
September 18, 2015Medical Communications digital, disruptive innovations, disruptive technologies, innovation, life sciences
The life sciences industry will be subject to major disruption from five key trends over the coming years, a report …
Number of mobile health apps quadruples in two years
September 18, 2015Medical Communications apps, clinical trials, communications, digital, mhealth, technology
The number of mobile health applications available to consumers has reached more than 165,000, as the industry for sensors and …
UK second in global innovation index
September 18, 2015Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo
The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …
Jamie McGarvey joins Astellas Pharma communications team
September 18, 2015Medical Communications Astellas, Astellas Pharma, Jamie McGarvey
Astellas Pharma has appointed Jamie McGarvey as senior manager of employee communications within its corporate affairs department. McGarvey will be …
Sandoz opens €150m manufacturing facility
September 18, 2015Manufacturing and Production Austria, BioInject, Novartis, Sandoz
Sandoz has opened a €150m state-of-the-art biopharmaceutical manufacturing facility in Schaftenau, Austria. Known as BioInject will result in the creation …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
